Analysts Set Astrana Health, Inc. (NASDAQ:ASTH) PT at $34.00

Astrana Health, Inc. (NASDAQ:ASTH) has received a consensus recommendation of “Moderate Buy” from the eight brokerages that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $34.00.

Several equities analysts have recently issued reports on the stock. Needham & Company LLC started coverage on shares of Astrana Health in a report on Friday, December 12th. They set a “buy” rating and a $28.00 price objective on the stock. Weiss Ratings reiterated a “sell (d+)” rating on shares of Astrana Health in a research note on Monday, December 29th. Zacks Research raised shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 11th. Truist Financial upped their price target on shares of Astrana Health from $37.00 to $38.00 and gave the company a “buy” rating in a research note on Friday, March 13th. Finally, BTIG Research lowered their price objective on shares of Astrana Health from $45.00 to $40.00 and set a “buy” rating for the company in a research note on Monday, February 2nd.

Institutional Trading of Astrana Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ASTH. 325 Capital LLC increased its holdings in shares of Astrana Health by 54.0% in the fourth quarter. 325 Capital LLC now owns 1,839,076 shares of the company’s stock valued at $45,627,000 after purchasing an additional 645,123 shares during the period. Wellington Management Group LLP lifted its holdings in shares of Astrana Health by 418.3% during the fourth quarter. Wellington Management Group LLP now owns 738,853 shares of the company’s stock worth $18,331,000 after purchasing an additional 596,293 shares during the period. Ameriprise Financial Inc. boosted its position in Astrana Health by 231.0% in the third quarter. Ameriprise Financial Inc. now owns 442,314 shares of the company’s stock valued at $12,540,000 after buying an additional 308,665 shares during the last quarter. Earnest Partners LLC purchased a new stake in Astrana Health in the fourth quarter valued at approximately $4,850,000. Finally, Pacer Advisors Inc. acquired a new position in Astrana Health in the 3rd quarter worth approximately $5,157,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Stock Down 0.9%

Shares of ASTH stock opened at $24.27 on Friday. The stock’s fifty day moving average price is $22.84 and its 200 day moving average price is $25.57. Astrana Health has a 1-year low of $18.08 and a 1-year high of $34.80. The company has a market cap of $1.35 billion, a price-to-earnings ratio of 52.76 and a beta of 0.91. The company has a debt-to-equity ratio of 1.25, a current ratio of 1.40 and a quick ratio of 1.40.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Monday, March 2nd. The company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.39. The company had revenue of $950.53 million during the quarter, compared to analysts’ expectations of $930.46 million. Astrana Health had a return on equity of 5.59% and a net margin of 0.71%.The firm’s revenue was up 42.9% compared to the same quarter last year. During the same period last year, the business posted ($0.15) earnings per share. On average, research analysts expect that Astrana Health will post 1.15 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.